These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 25288142
1. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia. Schultz CL, Mitra N, Schapira MM, Lambert MP. JAMA Pediatr; 2014 Oct; 168(10):e142214. PubMed ID: 25288142 [Abstract] [Full Text] [Related]
2. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals. Kime C, Klima J, Rose MJ, O'Brien SH. Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091 [Abstract] [Full Text] [Related]
3. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. De Mattia D, Del Principe D, Del Vecchio GC, Jankovic M, Arrighini A, Giordano P, Menichelli A, Mori P, Zecca M, Pession A. Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369 [Abstract] [Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG. Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [Abstract] [Full Text] [Related]
5. Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines. Witmer CM, Lambert MP, O'Brien SH, Neunert C. Pediatr Blood Cancer; 2016 Jul; 63(7):1227-31. PubMed ID: 26929009 [Abstract] [Full Text] [Related]
6. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP]. Le Meignen M, Mossler P, Mates M, Mathey C, Hass A, Monpoux F, Faverge B, Fortier G, Nguyen J, Belahbib L, Coache C, Chamoulli JM, Moulène E, Sirvent N, Michel G, Chambost H. Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127 [Abstract] [Full Text] [Related]
7. Successful implementation of a watchful waiting strategy for children with immune thrombocytopenia. Bekker E, Rosthøj S. Dan Med Bull; 2011 Apr; 58(4):A4252. PubMed ID: 21466762 [Abstract] [Full Text] [Related]
8. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months. Revel-Vilk S, Yacobovich J, Frank S, Ben-Ami T, Yechieli M, Shkalim V, Lebel A, Semo-Oz R, Tamary H. J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349 [Abstract] [Full Text] [Related]
9. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis. Cirasino L, Robino AM, Cattaneo M, Pioltelli PE, Pogliani EM, Terranova L, Morra E, Colombo P, Palmieri GA, Piscitelli P. Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712 [Abstract] [Full Text] [Related]
10. A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan. Shirahata A, Fujisawa K, Ishii E, Ohta S, Sako M, Takahashi Y, Taki M, Mimaya J, Kubota M, Miura T, Kitazawa J, Kajiwara M, Bessho F. J Pediatr Hematol Oncol; 2009 Jan; 31(1):27-32. PubMed ID: 19125083 [Abstract] [Full Text] [Related]
11. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS. Acta Haematol; 2006 Jan; 115(1-2):46-52. PubMed ID: 16424649 [Abstract] [Full Text] [Related]
12. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Sutor AH, Harms A, Kaufmehl K. Semin Thromb Hemost; 2001 Jun; 27(3):253-67. PubMed ID: 11446659 [Abstract] [Full Text] [Related]
13. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT, Gonzalez CE, Sandler SG. Paediatr Drugs; 2005 Jun; 7(5):325-36. PubMed ID: 16220997 [Abstract] [Full Text] [Related]
14. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia. Roganovic J, Letica-Crepulja M. Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):662-4. PubMed ID: 16933251 [Abstract] [Full Text] [Related]
15. Bleeding severity as an important outcome in childhood immune thrombocytopenia. Flores A, Buchanan GR. Pediatr Blood Cancer; 2013 Oct 15; 60 Suppl 1():S8-11. PubMed ID: 23109508 [Abstract] [Full Text] [Related]
16. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand. Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E. Pediatr Blood Cancer; 2017 Jan 15; 64(1):128-134. PubMed ID: 27571705 [Abstract] [Full Text] [Related]
18. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA. Hematology; 2017 Sep 15; 22(8):484-492. PubMed ID: 28415913 [Abstract] [Full Text] [Related]
19. Acute immune thrombocytopenic purpura in children and adolescents in South Dakota 1998-2004. Tancabelic J, Stout LA, Wetering J. S D J Med; 2005 Nov 15; 58(11):465-8. PubMed ID: 16502732 [Abstract] [Full Text] [Related]
20. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience. Del Vecchio GC, De Santis A, Giordano P, Amendola G, Baronci C, Del Principe D, Nobili B, Jankovic M, Ramenghi U, Russo G, Zecca M, De Mattia D, AIEOP ITP Study Group. Acta Haematol; 2008 Nov 15; 119(1):1-7. PubMed ID: 18176072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]